Literature DB >> 22907287

Characteristics of female sex workers in southern India willing and unwilling to participate in a placebo gel trial.

Barbara S Mensch1, Barbara A Friedland, Sharon A Abbott, Lauren L Katzen, Waimar Tun, Christine A Kelly, Avina Sarna, Aylur K Srikrishnan, Suniti Solomon.   

Abstract

Respondent-driven sampling was used to recruit female sex workers (FSWs) for a community survey conducted in southern India. After survey completion, participants were given a brochure describing a clinical trial that entailed daily use of a placebo vaginal gel for four months. This study assessed predictors of screening among survey respondents, predictors of enrollment among those eligible for the trial, and predictors of visit attendance and retention among those enrolled. FSWs who reported having symptoms of sexually transmitted infections (STI), engaging in sex work in the past month, and living in a subdistrict easily accessible by public transportation with a high concentration of FSWs, were more likely to screen. FSWs who had never been tested for HIV were more likely to enroll. This analysis suggests that the primary reason FSWs participated in the trial was a desire for health care-not other factors hypothesized to be important, e.g., HIV risk perception and poverty status.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22907287      PMCID: PMC3629903          DOI: 10.1007/s10461-012-0259-1

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  37 in total

Review 1.  Review of sampling hard-to-reach and hidden populations for HIV surveillance.

Authors:  Robert Magnani; Keith Sabin; Tobi Saidel; Douglas Heckathorn
Journal:  AIDS       Date:  2005-05       Impact factor: 4.177

2.  Using a 2-stage strategy with respondent-driven sampling to recruit a hard-to-reach population for a placebo microbicide gel clinical trial in Nellore, Andhra Pradesh (India).

Authors:  Waimar Tun; Lauren L Katzen; Sharon A Abbott; Aylur K Srikrishnan; Christine A Kelly; Avina Sarna; Barbara A Friedland; Suniti Solomon; Barbara S Mensch
Journal:  AIDS Behav       Date:  2015-02

3.  Acceptability and feasibility of Micralax applicators and of methyl cellulose gel placebo for large-scale clinical trials of vaginal microbicides.

Authors:  N Coetzee; K Blanchard; C Ellertson; A A Hoosen; B Friedland
Journal:  AIDS       Date:  2001-09-28       Impact factor: 4.177

4.  Women's willingness to participate in microbicide trials in Northern Thailand.

Authors:  K Tharawan; C Manopaiboon; C Ellertson; K Limpakarnjanarat; S Chaikummao; P H Kilmarx; K Blanchard; C Coggins; T D Mastro; C Elias
Journal:  J Acquir Immune Defic Syndr       Date:  2001-10-01       Impact factor: 3.731

5.  HIV vaccine trial willingness among injection and non-injection drug users in two urban centres, Barcelona and San Francisco.

Authors:  M Florencia Etcheverry; Paula J Lum; Jennifer L Evans; Emilia Sanchez; Elisa de Lazzari; Eva Mendez-Arancibia; Ernesto Sierra; José M Gatell; Kimberly Page; Joan Joseph
Journal:  Vaccine       Date:  2011-01-15       Impact factor: 3.641

6.  Willingness to volunteer in future preventive HIV vaccine trials: issues and perspectives from three U.S. communities.

Authors:  R P Strauss; S Sengupta; S Kegeles; E McLellan; D Metzger; S Eyre; F Khanani; C B Emrick; K M MacQueen
Journal:  J Acquir Immune Defic Syndr       Date:  2001-01-01       Impact factor: 3.731

7.  Readiness for HIV vaccine trials: changes in willingness and knowledge among high-risk populations in the HIV network for prevention trials. The HIVNET Vaccine Preparedness Study Protocol Team.

Authors:  B A Koblin; S Holte; B Lenderking; P Heagerty
Journal:  J Acquir Immune Defic Syndr       Date:  2000-08-15       Impact factor: 3.731

8.  HIV infection awareness and willingness to participate in future HIV vaccine trials across different risk groups in Abuja, Nigeria.

Authors:  Gambo Aliyu; Mukhtar Mohammad; Ahmed Saidu; Prosanta Mondal; Man Charurat; Alash'le Abimiku; Abdulsalami Nasidi; William Blattner
Journal:  AIDS Care       Date:  2010-10

9.  Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial.

Authors:  Stephanie Skoler-Karpoff; Gita Ramjee; Khatija Ahmed; Lydia Altini; Marlena Gehret Plagianos; Barbara Friedland; Sumen Govender; Alana De Kock; Nazira Cassim; Thesla Palanee; Gregory Dozier; Robin Maguire; Pekka Lahteenmaki
Journal:  Lancet       Date:  2008-12-06       Impact factor: 79.321

10.  Rectal microbicides for U.S. gay men. Are clinical trials needed? Are they feasible? HIVNET Vaccine Preparedness Study Protocol Team.

Authors:  M Gross; S P Buchbinder; C Celum; P Heagerty; G R Seage
Journal:  Sex Transm Dis       Date:  1998-07       Impact factor: 2.830

View more
  7 in total

1.  An evaluation of methods to improve the reporting of adherence in a placebo gel trial in Andhra Pradesh, India.

Authors:  Sharon A Abbott; Barbara A Friedland; Avina Sarna; Lauren L Katzen; Ulrike Rawiel; Aylur K Srikrishnan; C S Shalini; Waimar Tun; Christine A Kelly; Suniti Solomon; Barbara S Mensch
Journal:  AIDS Behav       Date:  2013-07

2.  Using a 2-stage strategy with respondent-driven sampling to recruit a hard-to-reach population for a placebo microbicide gel clinical trial in Nellore, Andhra Pradesh (India).

Authors:  Waimar Tun; Lauren L Katzen; Sharon A Abbott; Aylur K Srikrishnan; Christine A Kelly; Avina Sarna; Barbara A Friedland; Suniti Solomon; Barbara S Mensch
Journal:  AIDS Behav       Date:  2015-02

3.  Pattern and prevalence of substance use and dependence in two districts of Union Territory of Jammu & Kashmir: Special focus on opioids.

Authors:  Yasir Hassan Rather; Fazle Roub Bhat; Altaf Ahmad Malla; Marya Zahoor; Peerzada Ayash Ali Massodi; Saleem Yousuf
Journal:  J Family Med Prim Care       Date:  2021-01-30

4.  Pattern and prevalence of substance use and dependence in the Union Territory of Chandigarh: Results of a rapid assessment survey.

Authors:  Ajit Avasthi; Debasish Basu; B N Subodh; Pramod K Gupta; Nidhi Malhotra; Poonam Rani; Sunil Sharma
Journal:  Indian J Psychiatry       Date:  2017 Jul-Sep       Impact factor: 1.759

5.  The willingness to participate in biomedical research involving human beings in low- and middle-income countries: a systematic review.

Authors:  Joyce L Browne; Connie O Rees; Johannes J M van Delden; Irene Agyepong; Diederick E Grobbee; Ama Edwin; Kerstin Klipstein-Grobusch; Rieke van der Graaf
Journal:  Trop Med Int Health       Date:  2019-01-08       Impact factor: 2.622

6.  Sexually transmitted infections and reproductive health morbidity in a cohort of female sex workers screened for a microbicide feasibility study in Nellore, India.

Authors:  Avina Sarna; Barbara A Friedland; Aylur K Srikrishnan; Lauren L Katzen; Waimur Tun; Sharon A Abbott; Ulrike Rawiel; Christine A Kelly; C S Shalini; Suniti Solomon; Barbara S Mensch
Journal:  Glob J Health Sci       Date:  2013-02-24

7.  Understanding women's motivations to participate in MTN-003/VOICE, a phase 2b HIV prevention trial with low adherence.

Authors:  Ariana W K Katz; Barbara S Mensch; Kubashni Woeber; Petina Musara; Juliane Etima; Ariane van der Straten
Journal:  BMC Womens Health       Date:  2019-01-25       Impact factor: 2.809

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.